查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1627660

笔针市场：预测（2025-2030）

Pen Needle Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 120 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计在预测期内，笔用针头市场将以 9.27% 的复合年增长率增长，市场规模从 2025 年的 2,046,792,000 美元增至 2030 年的 3,189,012,000 美元。

笔式针头广泛用于将注射药物注射到体内。慢性病盛行率上升预计将成为预测期内市场成长的主要驱动力之一。然而，替代品的供应预计将限制未来几年的市场成长。

笔针市场驱动因素

  • 预计各种慢性病盛行率的增加将在预测期内推动市场发展。

癌症和糖尿病等慢性病盛行率的增加是预测期内市场成长的主要驱动力之一。根据国际糖尿病联盟的报告，20岁至79岁的糖尿病患者人数将从2017年的4.25亿增加到2022年的5.37亿，到2045年将增加到7.83亿。

此外，糖尿病日益增加的经济负担和全球医疗保健支出的增加预计也将增加未来几年对血糖监测快速诊断试剂套件的需求。根据国际糖尿病联盟（IDF）预测，2022年全球糖尿病医疗费用将约为9,660亿美元，较过去15年成长316%。

根据世界卫生组织（WHO）预测，2022年将有近130万人死于慢性B型肝炎和C型肝炎感染，其中约2.54亿人将死于B型肝炎，5,000万人死于C型肝炎感染。世界卫生组织在报告中称，2010年，估计有5.24亿人年龄在65岁及以上，占世界人口的8%，但到2050年，这一数字将几乎增加两倍，预计这一数字将达到约15亿。

营养不良、缺乏运动和有害饮酒会导致心血管疾病、癌症和慢性呼吸道疾病等慢性疾病的发生，似乎将直接影响未来几年的笔用针头市场。

北美占据主要市场份额：

按地区划分，笔针市场分为北美、南美、欧洲、中东和非洲以及亚太地区。由于慢性疾病患者数量的增加，佩恩针在北美迅速流行。根据疾病管制与预防中心的数据，美国有 608,336 人死于癌症。对最大限度减少副作用的药物输送系统的需求迅速增长，推动了该国对笔用针头的需求。

技术的进步和医疗保健成本的上升极大地推动了笔针市场的成长。例如，根据美国医疗保险和医疗补助服务中心的数据，2022 年美国医疗保健支出成长 4.1%，达到 4.5 兆美元。

在欧洲，各国政府正在放鬆监管并加速创新新药的核准流程，以满足人口老化日益增长的需求。该倡议旨在促进国内和国际製药公司的发展，并吸引新业务进入欧洲市场。

此外，国内市场参与者以併购形式增加的策略投资预计将加剧竞争，预计将进一步推动未来几年的市场成长机会。

此外，在亚太地区，人口健康意识的提高以及新型注射给药系统和技术使用市场的快速发展预计将在预测期内推动市场成长。中国和印度政府正在推出新政策来改善公民健康，包括扩大公立医疗机构的保险覆盖范围和标准化服务。

为什么要购买这份报告？

  • 富有洞察力的分析：获得涵盖关键和新兴地区的深入市场洞察，重点关注客户细分、政府政策和社会经济因素、消费者偏好、行业和其他子区隔。
  • 竞争格局：了解世界主要企业采取的策略策略，并了解透过正确的策略渗透市场的潜力。
  • 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议：利用洞察力做出策略决策，在动态环境中发现新的业务流和收益。
  • 受众广泛：对于新兴企业、研究机构、顾问、中小企业和大型企业有用且具有成本效益。

它有什么用？

产业和市场考虑因素、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范和影响、新产品开发和竞争影响。

调查范围

  • 2022年至2030年实际资料和预测
  • 成长机会、挑战、供应链前景、法规结构、顾客行为、趋势分析
  • 竞争定位、策略和市场占有率分析
  • 区域收益成长和预测分析，包括细分市场和国家
  • 公司概况（策略、产品、财务状况、主要发展等）

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行摘要

  • 主要发现
  • 分析师观点

第四章市场动态

  • 市场驱动因素
    • 包装需求不断成长
    • 永续性关注永续发展
  • 市场限制因素
    • 环境问题
    • 生产成本高
  • 波特五力分析
  • 产业价值链分析

第五章笔针市场分析：依类型

  • 介绍
  • 标准笔针
  • 安全笔针

第六章笔针市场分析：依长度

  • 介绍
  • 4毫米和5毫米
  • 6毫米和8毫米
  • 10毫米和12毫米

第七章笔针市场分析：依处理方式

  • 介绍
  • 胰岛素
  • Glucagon-Like Peptide-1
  • 生长激素

第八章笔针市场分析：按分销管道

  • 介绍
  • 在线的
  • 离线

第九章笔针市场分析：按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 其他的
  • 中东/非洲
    • 阿拉伯聯合大公国
    • 沙乌地阿拉伯
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第十章竞争环境及分析

  • 主要企业及策略分析
  • 新兴企业和市场盈利
  • 合併、收购、协议和合作
  • 供应商竞争力矩阵

第十一章 公司简介

  • Becton, Dickinson and Company
  • Glucorx
  • Braun Melsungen
  • Ypsomed
  • Novo Nordisk
  • HTL-Strefa
  • Ultimed, Inc.
  • Allison Medical, Inc.
  • Terumo Corporation
  • Owen Mumford, Ltd.
简介目录
Product Code: KSI061613464

The pen needle market is expected to grow at a CAGR of 9.27% over the forecast period to reach a total market size of US$3,189.012 million by 2030, increasing from US$2,046.792 million in 2025.

Pen needles are widely used to deliver injectable medication into the body. The rising prevalence of chronic disease is expected to be one of the prime drivers of market growth during the forecast period. However, the availability of substitutes is anticipated to restrain the market's growth in the coming years.

Pen Needle Market Drivers

  • The growing prevalence of various chronic diseases is anticipated to drive the market in the forecasted period.

The rising prevalence of chronic diseases such as cancer and diabetes is one of the prime drivers for the market growth during the forecast period. According to the International Diabetes Federation report, the number of people with diabetes under the age group of 20-79 years has risen from 425 million in 2017 to 537 million in 2022 and is expected to reach 783 million in 2045.

In addition, the rising economic burden of diabetes and increasing healthcare expenditure worldwide are also anticipated to increase the demand for rapid diagnostic kits for glucose monitoring in the coming years. According to the International Diabetes Federation (IDF), global healthcare expenditure on diabetes was around USD 966 billion in 2022, representing an increase of 316% over the last 15 years.

According to the World Health Organization (WHO), in 2022, nearly 1.3 million people died from chronic hepatitis B and C infection, and approximately 254 million people lived with hepatitis B, and 50 million people are living with hepatitis C. The WHO, in its report, stated that in 2010, an estimated 524 million people were aged 65 or older, which constitutes 8 percent of the world's population, and by 2050 this number is expected to nearly triple to about 1.5 billion, representing 16% of the world population.

Poor nutrition, physical inactivity, and the harmful use of alcohol contribute to the development of chronic conditions like cardiovascular diseases, cancer, and chronic respiratory disease, which will directly affect the market for pen needles in the coming years.

North America holds a significant share of the market:

By geography, the pen needle market is segmented into North America, South America, Europe, the Middle East, Africa, and the Asia Pacific. The pen needle is fast gaining traction in North America due to the growing number of chronic disease cases. According to the United States Centre for Disease Control and Prevention, 6,08,336 people died due to cancer in the United States. The burgeoning need for a targeted drug delivery system that causes minimal side effects drives the demand for pen needles in the country.

Advancements in technology and increased healthcare spending have significantly boosted the pen needle market growth. For instance, U.S. healthcare spending increased by 4.1% to reach USD 4.5 trillion in 2022, as per the United States Centre for Medicare and Medicaid Services.

In Europe, the government is easing regulations and speeding up the approval process for innovative new drugs to meet the increasing needs of the aging population. This initiative aims to promote domestic and foreign pharmaceutical companies and attract new businesses to the European market.

In addition, increasing strategic investment by domestic market players in the form of mergers and acquisitions increases the competition, which is further expected to propel market growth opportunities in the coming years.

Furthermore, in the Asia Pacific region, increasing health awareness among the population and the rapid market evolution in using new injectable drug delivery systems or technologies are expected to drive market growth during the forecast period. The Chinese and Indian governments are establishing new policies to improve the population's health, including coverage expansion of public healthcare institutions and standardizing their services.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Pen Needle market is segmented and analyzed as follows:

By Type

  • Standard Pen Needles
  • Safety Pen Needles

By Length

  • 4mm and 5mm
  • 6mm and 8mm
  • 10mm and 12mm

By Therapy

  • Insulin
  • Glucagon-like-Peptide-1
  • Growth Hormone

By Distribution Channel

  • Online
  • Offline

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Others
  • Middle East and Africa
  • UAE
  • Saudi Arabia
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
    • 4.1.1. Growing Demand for Packaging
    • 4.1.2. Increasing Focus on Sustainability
  • 4.2. Market Restraints
    • 4.2.1. Environmental Concerns
    • 4.2.2. High Production Cost
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. PEN NEEDLE MARKET ANALYSIS BY TYPE

  • 5.1. Introduction
  • 5.2. Standard Pen Needles
  • 5.3. Safety Pen Needles

6. PEN NEEDLE MARKET ANALYSIS BY LENGTH

  • 6.1. Introduction
  • 6.2. 4mm and 5mm
  • 6.3. 6mm and 8mm
  • 6.4. 10mm and 12mm

7. PEN NEEDLE MARKET ANALYSIS BY THERAPY

  • 7.1. Introduction
  • 7.2. Insulin
  • 7.3. Glucagon-like-Peptide-1
  • 7.4. Growth Hormone

8. PEN NEEDLE MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 8.1. Introduction
  • 8.2. Online
  • 8.3. Offline

9. PEN NEEDLE MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. United States
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. UK
    • 9.4.2. Germany
    • 9.4.3. France
    • 9.4.4. Spain
    • 9.4.5. Italy
    • 9.4.6. Others
  • 9.5. Middle East and Africa
    • 9.5.1. UAE
    • 9.5.2. Saudi Arabia
    • 9.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. Japan
    • 9.6.2. China
    • 9.6.3. India
    • 9.6.4. South Korea
    • 9.6.5. Indonesia
    • 9.6.6. Thailand
    • 9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Emerging Players and Market Lucrativeness
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Vendor Competitiveness Matrix

11. COMPANY PROFILES

  • 11.1. Becton, Dickinson and Company
  • 11.2. Glucorx
  • 11.3. Braun Melsungen
  • 11.4. Ypsomed
  • 11.5. Novo Nordisk
  • 11.6. HTL-Strefa
  • 11.7. Ultimed, Inc.
  • 11.8. Allison Medical, Inc.
  • 11.9. Terumo Corporation
  • 11.10. Owen Mumford, Ltd.